AbstractThe most common complication seen in inflammatory bowel disease (IBD) patients is iron deficiency anaemia (IDA). Symptoms such as chronic fatigue can be as debilitating to IBD patients as pathological symptoms of abdominal pain and diarrhoea. Recognising and correcting anaemia may be as important as managing IBD symptoms and improving overall quality of life. Thus, iron replacement should be commenced the moment IDA is identified. Although intravenous iron is now considered standard treatment for IBD patients in Europe, oral iron still appears to be the preferred option. Advantages of oral iron include greater availability, lower costs and ease of applicability. However, its multitude of side effects, impact on the microbiome and further exacerbating IBD activity can have consequences on patient compliance. The newer oral iron formulations show promising safety and efficacy data with a good side effect profile. Intravenous iron formulations bypass the gastrointestinal tract absorption thereby leading to less side effects. Multiple studies have shown its superiority compared to oral formulations although its risk for hypersensitivity reactions continue to lead to clinician hesitancy in prescribing this formulation. This article provides an updated review on diagnosis and management of IDA in IBD patients, discussing the newer oral and intravenous formulations.
CitationKumar A, Brookes MJ. (2020) Iron Therapy in Inflammatory Bowel Disease. Nutrients, 12(11):3478. https://doi.org/10.3390/nu12113478
PubMed ID33198376 (pubmed)
Description© 2020 The Authors. Published by MDPI. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.3390/nu12113478
Except where otherwise noted, this item's license is described as Licence for published version: Creative Commons Attribution 4.0 International
- Iron Therapy in Inflammatory Bowel Disease.
- Authors: Kumar A, Brookes MJ
- Issue date: 2020 Nov 12
- Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease.
- Authors: Aksan A, Işık H, Radeke HH, Dignass A, Stein J
- Issue date: 2017 May
- Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.
- Authors: Nielsen OH, Soendergaard C, Vikner ME, Weiss G
- Issue date: 2018 Jan 13
- Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
- Authors: Khoury A, Pagan KA, Farland MZ
- Issue date: 2021 Feb